Avalo Therapeutics, Inc. (AVTX) Earnings
NASDAQ·Healthcare·Biotechnology
$7.00
+1.37%
Mkt Cap $379.16M
EPS — Estimate vs Actual
Mkt Cap
$379.16M
P/E
—
Fwd P/E
—
P/S
6426.51
Rev TTM
—
EPS TTM
-$5.83
NASDAQ·Healthcare·Biotechnology
$7.00
+1.37%
Mkt Cap $379.16M
Mkt Cap
$379.16M
P/E
—
Fwd P/E
—
P/S
6426.51
Rev TTM
—
EPS TTM
-$5.83